Infectious Diseases Ongoing Projects Sponsor Protocol Code Trial Name Principal Investigator Phase Therapeutic Area Diseases and Conditions AstraZeneca D9185C00001 A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA) ÖNDER ERGÖNÜL (Prof.Dr.) Phase 3 Infectious Diseases Viral Diseases